Beyond secretion of insulin,the novel function of β cell in regulating glucose homeostasis

February 07, 2021

In a new study published in Journal of Extracellular Vesicles, Chen-Yu Zhang's group and Antonio Vidal-Puig's group at University of Cambridge report that pancreatic β cells secrete miR-29 family members (miR-29a, miR-29b and miR-29c) in response to high levels of free fatty acids (FFAs). These β cell-derived miR-29s are delivered to the liver, promoting insulin resistance and enhancing hepatic glucose output.

Over 100 years after insulin was discovered, it was believed that pancreatic β cells only secreted a single hormone--insulin. Pancreatic β cell-derived insulin regulates glucose homeostasis by binding with the insulin receptors located in the liver, skeletal muscle, adipose tissues and other peripheral organs. The discovery of insulin and its receptor was essential to understand the mechanisms controlling glucose homeostasis and the pathogenesis of type 2 diabetes defined by defective insulin secretion, signal transduction and insulin resistance. However, glucose homeostasis also depends on the integrated coordination of multiple organs, talking to each other to effectively control glucose metabolism. Understanding the crosstalk between organs is still incomplete, which has greatly limited the rational approach to type 2 diabetes treatment.

Previous work from Chen-Yu Zhang's group has identified extracellular miRNA as a new form of cell-to-cell communication. This group was the first reporting the different secretion of miRNAs in response to physiological or pathological states and the uptake and function of secreted miRNAs in recipient cells. In the current study, this group used three independent animal models (ob/ob, HFD and fasted mice) to show that pathological- and physiological- high levels of FFAs induce the secretion of miR-29s from pancreatic β cells. Of relevance, miR-29s is increased in the plasma of obese humans in comparison to lean humans. To address the target organ and functional role of secreted miR-29s, they generated three kinds of transgenic mice. First, mice overexpressed miR-29s or a traceable mutant miR-29a in pancreatic β cells showed that β cell-derived miR-29s is taken by the liver attenuating the normal suppression of insulin on glucose output mediated by targeting p85 α (a regulatory subunit of PI3K) promoting systemic insulin resistance. More importantly, miR-29s deficiency in β cells significantly improved the insulin sensitivity in mice fed on HFD, indicating that β cell-derived miR-29s play an essential role in the development of liver insulin resistance.

This work is essential for the following reasons:
  1. This study finds a novel, unexpected function of the islet controlling glucose homeostasis. Beyond the secretion of insulin, β cells also secrete functional exosomal miRNAs that contribute to an integrated glucose homeostasis loop, which largely extends our understanding of islet function.
  2. This study also reveals a new mechanism linking obesity/FFAs-induced insulin resistance in type 2 diabetes's pathogenesis. Obesity or high levels of FFAs may not only directly affect liver, skeletal muscle and white adipose tissue and cause insulin resistance, but also regulate exogenous secreted miRNAs to indirectly result in pathophysiology as well.
  3. This study first time demonstrates that pancreatic β cell contributes to insulin resistance development at a very early stage. More importantly, the secreted miR-29s are increased before the onset of insulin resistance in ob/ob or DIO mice, indicating secreted miR-29s may be the factors that initiate the development of insulin resistance;
  4. This study reveals the new functions of secreted miRNAs;
  5. This study provides an alternative strategy for the treatment of insulin resistance and type 2 diabetes. Given the obvious significance of insulin, current treatments predominantly concentrate on mechanisms of insulin action. This study suggests that it might be insufficient to treat insulin resistance by only targeting insulin and its direct signal transduction and offers an alternative strategy involving secreted miRNAs from the β cell.

Chen-Yu Zhang believes that pancreatic islet-derived miRNAs might contribute to a diversified functional spectrum. Thus, more studies are needed to discover the functional roles of pancreatic islet-derived miRNAs and subsequently establish mechanisms that underlie integrated multi-organ regulation on glucose homeostasis.
The researchers of this project include Jing Li, Yujing Zhang, Yangyang Ye, Dameng Li, Yuchen Liu, Eunyoung Lee, Mingliang Zhang, Xin Dai, Xiang Zhang, Shibei Wang, Junfeng Zhang, Weiping Jia, Ke Zen, Antonio Vidal-Puig, Xiaohong Jiang, Chen-Yu Zhang.

This work was supported by grants the National Natural Science Foundation of China (31741066, 31200874, 31771666, 31200969, 81101330, 31271378, 81250044, and 31972912), the National Basic Research Program of China (973 Program) (No. 2011CB504803), the National Key Research and Development Program of China (2017YFC0909700), the Natural Science Foundation of Jiangsu Province, China (BK20130890, BK2011013 and BK2012014), the Fundamental Research Funds for the Central Universities (020814380148, 020514380226), the National Science Fund for Distinguished Young Scholars (81025019) and the programme for New Century Excellent Talents in University from the Ministry of Education, China (NCET-12-0261). Vidal-Puig is funded by MRC-MDU programme grant.

Li et al.: "Pancreatic β cells control glucose homeostasis via the secretion of exosomal miR-29 family" published on Journal of Extracellular Vesicle, 21 January 2021.

Author contact:
Prof. Chen-Yu Zhang
(Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chinese Academy of Medical Sciences Research Unit of Extracellular RNA, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China)
Tel: +86-25-89680245;

Nanjing University School of Life Sciences

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to